CLOPID 75 MG

Country: Israel

Language: English

Source: Ministry of Health

Active ingredient:

CLOPIDOGREL 75 MG

Available from:

TARO INTERNATIONAL LTD

ATC code:

B01AC04

Pharmaceutical form:

FILM COATED TABLETS

Administration route:

PER OS

Manufactured by:

PHARMATHEN S.A., GREECE

Therapeutic group:

CLOPIDOGREL

Therapeutic indications:

Clopidogrel is indicated in adults for the prevention of atherothrombotic events as follows:Patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.Patients suffering from Acute Coronary Syndrome- Non-ST segment elevation acute coronary syndrome (unstable angina/non-Q-wave myocardial infarction (MI)), including patients undergoing a stent replacement following percutaneous coronary intervention, in combination with acetylsalicylic acid (ASA). - ST segment elevation acute myocardial infarction, in combination with ASA in medically treated patients eligible for thrombolytic therapy

Authorization date:

2010-09-01